ScholarIQanswers from OpenAlex
The University of Kansas Cancer Center
InstitutionResearch output, impact & collaborations
The University of Kansas Cancer Center is a institution indexed in ScholarIQ from OpenAlex.
What is known about The University of Kansas Cancer Center?
ScholarIQrecord summary
The University of Kansas Cancer Center is a research organisation in Kansas City, US. OpenAlex records 3,692 works and 284,323 citations for it. 699 researchers list it as their most recent affiliation.
How many works does The University of Kansas Cancer Center have?
ScholarIQindexed works
The University of Kansas Cancer Center has 3,692 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does The University of Kansas Cancer Center have?
ScholarIQcitation count
The University of Kansas Cancer Center has 284,323 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at The University of Kansas Cancer Center?
ScholarIQresearcher count
The University of Kansas Cancer Center has 699 researchers in the ScholarIQ index.
What is the average h-index at The University of Kansas Cancer Center?
ScholarIQavg h-index
The University of Kansas Cancer Center has an average h-index of 66.7 in OpenAlex.
What is the ROR of The University of Kansas Cancer Center?
ScholarIQror
The ROR for The University of Kansas Cancer Center is on the source record.
What is the OpenAlex record for The University of Kansas Cancer Center?
ScholarIQopenalex
The OpenAlex for The University of Kansas Cancer Center is on the source record.
Who are the most-cited researchers behind The University of Kansas Cancer Center?
ScholarIQtop researchers by citations
What are the most-cited papers on The University of Kansas Cancer Center?
ScholarIQmost cited works
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
M. William Audeh, James Carmichael, Richard T. Penson, Michael Friedländer, Bethan Powell, Katherine M. Bell‐McGuinn, Clare L. Scott, Jeffrey N. Weitzel, Ana Oaknin, Niklas Loman, Karen H. Lu, Rita K. Schmutzler, Ursula A. Matulonis, Mark Wickens, Andrew Tutt
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Mary B. Daly, Tuya Pal, Michael P. Berry, Saundra S. Buys, Patricia Dickson, Susan M. Domchek, Ahmed Elkhanany, Susan Friedman, Michael Goggins, Mollie L. Hutton, CGC, Beth Y. Karlan, Seema Khan, Catherine Klein, Wendy Kohlmann, CGC, Allison W. Kurian, Christine Laronga, Jennifer K. Litton, Julie Mak, LCGC, Carolyn S. Menendez, Sofía D. Merajver, Barbara S. Norquist, Kenneth Offit, Holly J. Pederson, Gwen Reiser, CGC, Leigha Senter-Jamieson, CGC, Kristen M. Shannon, Rebecca Shatsky, Kala Visvanathan, Jeffrey N. Weitzel, Myra Wick, Kari B. Wisinski, Matthew B. Yurgelun, Susan Darlow, Mary A. Dwyer
A Population-Based Study of Genes Previously Implicated in Breast Cancer
Chunling Hu, Steven N. Hart, Rohan Gnanaolivu, Hongyan Huang, Kun Y. Lee, Jie Na, Chi Gao, Jenna Lilyquist, Siddhartha Yadav, Nicholas Boddicker, Raed Samara, Josh Klebba, Christine B. Ambrosone, Hoda Anton‐Culver, Paul L. Auer, Elisa V. Bandera, Leslie Bernstein, Kimberly A. Bertrand, Elizabeth S. Burnside, Brian D. Carter, Heather Eliassen, Susan M. Gapstur, Mia M. Gaudet, Christopher A. Haiman, James M. Hodge, David J. Hunter, Eric J. Jacobs, Esther M. John, Charles Kooperberg, Allison W. Kurian, Loı̈c Le Marchand, Sara Lindströem, Tricia Lindstrom, Huiyan Ma, Susan L. Neuhausen, Polly A. Newcomb, Katie M. O’Brien, Janet E. Olson, Irene M. Ong, Tuya Pal, Julie R. Palmer, Alpa V. Patel, Sonya Reid, Lynn Rosenberg, Dale P. Sandler, Christopher J. Scott, Rulla M. Tamimi, Jack A. Taylor, Amy Trentham‐Dietz, Celine M. Vachon, Clarice R. Weinberg, Song Yao, Argyrios Ziogas, Jeffrey N. Weitzel, David E. Goldgar, Susan M. Domchek, Katherine L. Nathanson, Peter Kraft, Eric C. Polley, Fergus J. Couch
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
Mary B. Daly, Robert Pilarski, Michael P. Berry, Saundra S. Buys, Meagan Farmer, Susan Friedman, Judy E. Garber, Noah D. Kauff, Seema Khan, Catherine Klein, Wendy Kohlmann, Allison W. Kurian, Jennifer K. Litton, Lisa Madlensky, Sofía D. Merajver, Kenneth Offit, Tuya Pal, Gwen Reiser, Kristen M. Shannon, Elizabeth M. Swisher, Shaveta Vinayak, Nicoleta Voian, Jeffrey N. Weitzel, Myra Wick, Georgia L. Wiesner, Mary A. Dwyer, Susan Darlow
Genetic/Familial High-Risk Assessment: Breast and Ovarian
Mary B. Daly, Jennifer E. Axilbund, Saundra S. Buys, Beth Crawford, Carolyn Farrell, Susan Friedman, Judy E. Garber, Salil Goorha, Stephen B. Gruber, Heather Hampel, Virginia Kaklamani, Wendy Kohlmann, Allison W. Kurian, Jennifer K. Litton, P. Kelly Marcom, Robert L. Nussbaum, Kenneth Offit, Tuya Pal, Boris Pasche, Robert Pilarski, Gwen Reiser, Kristen M. Shannon, Jeffrey R. Smith, Elizabeth M. Swisher, Jeffrey N. Weitzel
How much of the research on The University of Kansas Cancer Center is open access?
ScholarIQopen access share
88%OPEN ACCESS